Forward MR analysis showed that genetic prediction of increased serum vitamin B12 concentrations were robustly associated with an elevated risk of NAFLD
Huang Y, et al
You might have seen advertisements for the medication online, but make no mistake: Retatrutide has not been approved by the FDA and is not expected to receive approval before 2027
Ingredients: 37% conjugated linoleic acid CLA, 14,8% green tea extract, soybean oil, 7,4% L-carnitine, capsule (gelatine, glycerin, water, colour: E172) Purpose The product is designed for pro-active persons and sportsmen
Second, and more fundamentally, compounding eligibility is not drug approval
AZ: Conceptualization, Writing review & editing